Loading clinical trials...
Loading clinical trials...
Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-820836 in Healthy Subjects
Conditions
Interventions
BMS-820836
BMS-820836
+10 more
Locations
1
Canada
Local Institution
Toronto, Ontario, Canada
Start Date
July 1, 2008
Primary Completion Date
April 1, 2009
Completion Date
April 1, 2009
Last Updated
January 25, 2011
NCT07360600
NCT06793397
NCT07478393
NCT04123314
NCT06906939
NCT05851898
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions